A new trading day began on Monday, with Tempest Therapeutics Inc (NASDAQ: TPST) stock price up 8.54% from the previous day of trading, before settling in for the closing price of $8.25. TPST’s price has ranged from $5.35 to $42.12 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 48.05%. With a float of $3.37 million, this company’s outstanding shares have now reached $3.52 million.
Let’s determine the extent of company efficiency that accounts for 25 employees. In terms of profitability, gross margin is 18.11%, operating margin of -9256.58%, and the pretax margin is -9217.9%.
Tempest Therapeutics Inc (TPST) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tempest Therapeutics Inc is 8.46%, while institutional ownership is 4.28%. The most recent insider transaction that took place on Aug 12 ’24, was worth 426,993. Before that another transaction happened on Aug 08 ’24, when Company’s 10% Owner sold 400,000 for $1.35, making the entire transaction worth $540,040. This insider now owns 597,940 shares in total.
Tempest Therapeutics Inc (TPST) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.92% during the next five years compared to 50.16% growth over the previous five years of trading.
Tempest Therapeutics Inc (NASDAQ: TPST) Trading Performance Indicators
Here are Tempest Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -18.08, a number that is poised to hit -2.61 in the next quarter and is forecasted to reach -10.38 in one year’s time.
Technical Analysis of Tempest Therapeutics Inc (TPST)
Looking closely at Tempest Therapeutics Inc (NASDAQ: TPST), its last 5-days average volume was 0.55 million, which is a jump from its year-to-date volume of 87557.0. As of the previous 9 days, the stock’s Stochastic %D was 65.59%. Additionally, its Average True Range was 0.82.
During the past 100 days, Tempest Therapeutics Inc’s (TPST) raw stochastic average was set at 46.41%, which indicates a significant decrease from 50.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.35% in the past 14 days, which was higher than the 82.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.22, while its 200-day Moving Average is $11.69. However, in the short run, Tempest Therapeutics Inc’s stock first resistance to watch stands at $11.02. Second resistance stands at $13.10. The third major resistance level sits at $14.24. If the price goes on to break the first support level at $7.80, it is likely to go to the next support level at $6.66. Now, if the price goes above the second support level, the third support stands at $4.58.
Tempest Therapeutics Inc (NASDAQ: TPST) Key Stats
With a market capitalization of 32.96 million, the company has a total of 3,682K Shares Outstanding. Currently, annual sales are 0 K while annual income is -41,840 K. The company’s previous quarter sales were 0 K while its latest quarter income was -10,860 K.
